In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Eric AniogoDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0001-6951-2977 Lindsay WilliamsDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.
Teresa HongDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.
Patty WongDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.
Susanta K HuiDepartment of Radiation Oncology, Beckman Research Institute and Medical Center, City of Hope, Duarte, CA 91010, USA.
Hemendra GhimireDepartment of Radiation Oncology, Beckman Research Institute and Medical Center, City of Hope, Duarte, CA 91010, USA.ORCID 0009-0009-9097-8662 Erasmus K PokuRadiopharmacy, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.
David M ColcherDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0001-6647-2850 Paul J YazakiDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0003-2626-3303 John E ShivelyDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0002-7763-770X Maciej KujawskiDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0002-9701-5211 Funding
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3MTargeted radiation and immunocytokine therapy for CEA positive malignanciesR01CA283603 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI John Ernest Shively, JEFFREY Y WONG · 2023 to 2026
$2.7MNCI NIH HHS P30CA033572NCI NIH HHS R01 CA283603
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
breast cancercolon cancerfusion proteinsimmunotherapyradiation therapyTAG-72
Identifiers
PMID40361381
PMCPMC12071099
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390